SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-18-003574
Filing Date
2018-05-10
Accepted
2018-05-10 16:31:14
Documents
38
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q s110045_10q.htm 10-Q 385784
2 EXHIBIT 31.1 s110045_ex31-1.htm EX-31.1 10625
3 EXHIBIT 31.2 s110045_ex31-2.htm EX-31.2 10396
4 EXHIBIT 32.1 s110045_ex32-1.htm EX-32.1 7178
  Complete submission text file 0001615774-18-003574.txt   2465923

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE avxl-20180331.xml EX-101.INS 558937
6 XBRL SCHEMA FILE avxl-20180331.xsd EX-101.SCH 28627
7 XBRL CALCULATION FILE avxl-20180331_cal.xml EX-101.CAL 25388
8 XBRL DEFINITION FILE avxl-20180331_def.xml EX-101.DEF 88484
9 XBRL LABEL FILE avxl-20180331_lab.xml EX-101.LAB 226805
10 XBRL PRESENTATION FILE avxl-20180331_pre.xml EX-101.PRE 138808
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 18823015
SIC: 8731 Services-Commercial Physical & Biological Research